INTERNATIONAL PATENT F O R U M A P R I L , L O N D O N S H E R A T O N P A R K L A N E H O T E L S P E A K E R S I N C L U D E

Transcription

1 A P R I L , S H E R A T O N P A R K L A N E H O T E L L E A D S P O N S O R S P O N S O R S S U P P O R T E D B Y S P E A K E R S I N C L U D E Frédéric Caillaud, L Oréal Vincent Couteau, Atos Sarah Dixon, Johnson Matthey Roya Ghafele, University of Oxford and University of Edinburgh Mark Guetlich, USPTO Matthew Goodwin, Unilever Catriona Hammer, GE Healthcare Andrew Hammond, Valea Hubert Kiehl, Groupe SEB Belinda Gascoyne, IBM James Pooley, WIPO Dietmar Pressner, DSM Paul Ranjard, Wan Hui Da David Rosenberg, Glaxo SmithKline Kevin Scott, Philips Bart Van der Stockt, UNILIN Richard Vary, Nokia Monica Winghart, ROL Group and Chair of Association of Corporate Counsel IP Committee YIN Xintian, Wan Hui Da Dr Qinghong Xu, Lung Tin

2 THE EVENT DEVELOPING THE PROGRAMME TO ENSURE UTMOST RELEVANCE TO STRATEGIC CONCERNS. Managing IP is delighted to announce that it will be holding the 3rd annual International Patent Forum in London during April This forum will represent a development from our previous International Patent events, based upon the most upto-date research and consultation conducted within the industry. Thus an emphasis will be placed upon practical guidance to promoting the monetisation of IP and utilising intellectual assets as a significant driver of profits. In order to create a forum for optimum ideas sharing on practical approaches, we shall strive to deliver an impressive set of names from leading European corporations, both as speakers and as attendees. This year we will also be taking particular note of the fundamental role played by China and Chinese IP practice within the running and management of IP in European companies. Thus an Asian perspective will be incorporated into a variety of the vital discussions at hand. Furthermore, discussions will be held to address the various complexities faced by pharmaceutical companies today and for the future. A SELECTION OF LAST YEAR S DELEGATES Alcatel-Lucent ENFIELD ArjoHuntleigh Article One Partners Astrazeneca Atos Healthcare Audi BNDES British American Tobacco British High Commission British Sky Broadcasting Limited BT BTG International Cambridge Display Technology Ltd Ceravision Limited Chimar Hellas SA Cipla Ltd Diageo e2v Technologies Edwards Limited EFL Element Six Limited Enterprise Ireland KL Ericsson Ltd European Patent Office France Telecom Orange GE Healthcare Huntsman Advanced Materials Husqvarna AB ICAP Ocean Tomo Iddex Intelligent Energy IPO Irdeto JA Kemp Jaguar Land Rover JETRO Düsseldorf Centre Kraft Foods Legal Aid Department Liu Shen & Associates Max Planck Institute for Intellectual Property and Competition Law Medecins Sans Frontieres MetaSwitch Networks Mexican Association of Pharmaceutical Research MSD National Institute of Immunology NDS Limited NEC Corporation Netcall NEUTEC R&D Industry and Trade Inc NewSouth Innovations Pty Limited (UNSW) NI Group Limited Nokia GmbH Nokia Siemens Networks UK Nokia UK Ltd Oclaro Oxis Energy Patent Office of the Republic of Poland Patentica Petrowell Limited Queen Mary University of London Richemont International SCA Hygiene Products AB SCEE Siemens Plc Singh & Singh Skype Smartmatic Limited Sony Europe Limited Telecommunication Planning Research Institute of MIIT P.R.China Tetra Pak TMI Associates UBM TechInsights UCL UK Intellectual Property Office Unilever United States Patent and Trademark Office University of Cambridge University of Technology US Embassy, London Vectura Ltd Vestas Technology UK Vivien Chan & Co WIPO WIPR Zydus Research Centre SHIP ENQUIRIES MELANIE PETCH mpetch@euromoneyplc.com

3 DAY Registration and coffee 9.00 Opening remarks: Andrew Hammond, European patent attorney, Valea 9.10 Keynote address: James Pooley, deputy director general, WIPO 9.30 IP & Business Focus: How to maximize the monetization of your patents Aligning your patent portfolio with the broader business strategy of your company: What is needed in order to effectively build and maintain a thriving profit centre? Conducting and applying patent valuation Transactional matters and patent management: licensing; M&A, purchasing other s portfolios, due diligence and insightful budgeting for reforms. Open innovation: Promote development; prevent theft. Bart Van der Stockt, managing director, UNILIN Frédéric Caillaud, director of licensing and business development, L Oréal Vincent Couteau, head of legal IPR, Atos Matthew Goodwin, global head of patents, Unilever Andrew Hammond, European patent attorney, Valea Coffee Russia Focus Key trends in patent protection and enforcement in Russia Patents as a key to business expansion: produced in Russia Non-practicing entities in Russia: threats and defensive tactics Natalia Gulyaeva, partner and head of IP, media & technology practice, Hogan Lovells CIS Europe, the unitary patent and unified court European patents: How does the land lie now? How should companies comply with changes (whether they like them or not)? Implications for enforcement strategies Belinda Gascoyne, IP counsel, IBM Gordon Harris, partner, Wragge & Co David Barron, partner, Wragge & Co David Rosenberg, industry affairs manager, GlaxoSmithKline Lunch Doing business in China: Ensure that your patented assets in China are making you money Overview: where are things actually at in terms of patent protection in China now? An update from the ground A guide to business culture in China Trade secret protection and ensuring the safety of lucrative business partnerships in China Qinghong Xu, partner, Lung Tin Roya Ghafele, research fellow, University of Oxford and chair of IP, University of Edinburgh Practical implications of the US Patent reform one year on Has the AIA addressed the problem of pendency? If so how? How has the AIA addressed excessive enforcement costs? Global harmonization: Are we there yet? Over all reflection on the patents industry legal and business- in the US today Dietmar Pressner, global vice president IP, DSM Sarah Dixon, director of patents and licensing, Johnson Matthey Anthony Tridico, partner, Finnegan Bryan Diner, partner, Finnegan Africa Focus Navigating a complex terrain: What you must know about IP across a diverse continent and mastering cross-border issues Key developments in African patent law and the legal framework African hot-spots : Where to invest and when? Dario Tanziani, firm chairman, Adams & Adams Darren Olivier, partner, Adams & Adams Coffee Important tax take home points for in-house IP Counsel: Overview and practical guide The patent box demystified: A practical guide to the new tax breaks for patents What is being incentivised and how? How can corporations incorporate the reforms into their IP monetization plans? Tax, intangibles and reputational risk: IP and brand management as part of the bigger picture Paul Wilmhurst, principal transfer pricing and valuation, Charles River Associates Tom Scott, partner, McDermott Will & Emery Close of day one and cocktail reception

4 DAY Registration and coffee 9.00 Opening remarks: James Nurton, managing editor, Managing IP, UK 9.10 Keynote address: Mark Guetlich, senior patent counsel and director of patent policy (international affairs) USPTO 9.30 Latest legislative updates of China s Patent Law amendment An overview of the amendments: Have we seen a revision of all major IP statutes in China? What are SIPO s ambitions? What implications will the amendments have for foreign corporate patent practice in China? YIN Xintian, senior partner, Wan Hui Da Hubert Kiehl, industrial and intellectual property director, Groupe SEB Paul Ranjard, of counsel, Wan Hui Da Licensing: Best practices Assessing types of licenses and apt applications Licenses and tech transfer Utilizing patent pools and standards setting Tips for writing and negotiating good licenses How to pre-empt and prevent post licensing disputes Monica Winghart, general counsel, ROL Group and Chair of Association of Corporate Counsel IP Committee Catriona Hammer, senior counsel, Intellectual Property, GE Healthcare Roya Ghafele, research fellow, University of Oxford and chair of IP, University of Edinburgh Kevin Scott, principal IP counsel, Philips Coffee India focus Recent trends in Indian patent litigation: Pharmaceuticals, telecommunications and beyond How does the procedure for filing patent infringement actions work Prathiba Singh, managing partner, Singh & Singh Brazil focus An update on legal developments in the region Brazil s growing importance and how to be effectively involved and well protected In anticipation of the World Cup 2014: IP and the world of international sporting events David Merrylees, engineer and industrial property agent, Dannemann Siemsen Bigler & Ipanema Moreira Peter Dirk Siemsen, attorney, industrial property agent, Dannemann, Siemsen, Bigler & Ipanema Moreira Lunch High tech, electronics and software: What are the Smartphone Wars teaching/warning us? An overview of the past 12 months in high tech industries and the wars Standards and competition in the industry: Licensing and FRAND How will the industry be impacted by European reforms and how should we mitigate against any new risks? Smartphone wars and cross jurisdictional divides Chris Benson, partner, Harrison Goddard Foote Pablo Tapia, senior IP attorney, Microsoft Richard Vary, head of litigation, Nokia Adam Pilcher, patent manager, Metaswitch Coffee Pharmaceutical Industry focus The AstraZeneca case: A renewed look at regulation around competition in pharma What are the significant implications of the Prometheus and myriad rulings? A Chinese perspective on AstraZeneca, Prometheus and Myriad Tech transfer, open innovation and the key to successful partnerships Developments regarding the interface between IP and access to pharmaceuticals in develpoing countries Harry Thangaraj, scientific and administrative coordinator of the access to pharmaceuticals, St George s University Mike Nelson, partner, Harrison Goddard Foote Kate Taylor, partner, Harrison Goddard Foote Stephen Zou, partner, Lung Tin Marek Lazewski, partner, Lazewski Depo & Partners Close of conference

5 SHIP OPTIONS Limited positions are available for firms to come on board as the sponsor for their chosen topic or jurisdiction. Please see overleaf for the provisional programme. LEAD PANEL COCKTAIL COUNTRY EXHIBITION Cost US$20,000 US$15,000 US$12,500 US$10,000 US$6,500 Number available Chair day one or day two Host cocktail reception (including 10 minute speech) Speaking slot - moderator Speaking slot - panellist Exhibition space Advert in Managing IP FULL PAGE FULL PAGE FULL PAGE FULL PAGE HALF PAGE Logo on pre-event marketing materials Logo on event signage Logo featured in post-conference article Complimentary event pass for staff Complimentary event pass for guests Post-conference list of attendees

6 1 Register (Please tick one box) To Register Booking fee Super early booking rate (before January 25, 2013) Advisers, consultants, private practitioners, service providers 995 In-house counsel at corporates, patent counsel, academics and R&D professionals FREE Online Telephone Early booking rate (before February 15, 2013) 1,095 FREE Fax Standard booking rate 1,295 (after February 15, 2013) +20% VAT TOTAL REMITTANCE 2 Your details for registration (Please print) Delegate 1 Delegate 2 Name: Name: Job title: Job title: FREE mfabri@euromoneyplc.com Mail Marina Fabri Legal Media Group Nestor House Playhouse Yard London EC4V 5EX, UK Company: Address: Postcode: Country: Tel: Company: Address: Postcode: Country: Tel: CANCELLATION POLICY: If you cannot attend you must cancel your registration in writing by 18 March 2013 to receive a refund less a 10% administration charge. Cancellations received after 18 March 2013, or no shows, are liable for the full conference fee (where applicable). You may send a substitute to attend in your place at no extra charge, however we must know by 12 April 2013 via . We cannot accept verbal cancellations. If you make your booking online, by or via the telephone, you are automatically adhering to our terms and conditions. 3 Method of payment Payment must be received before the conference date to guarantee your place. Please tick box to select payment method and sign agreement in box Bank transfer quoting reference number Account ; Sort code IBAN no GB 97 LOYD Lloyds Bank TSB Plc, City Office, PO Box 72, Bailey Drive, Gillingham Business Park, Gillingham, Kent, ME8 0LS, UK $ Account ; Sort code IBAN no GB 29 LOYD Account ; Sort code IBAN no GB 25 LOYD SWIFT address: LOYD GB2 LCTY To make a payment by credit card, please register and pay online at: or call Please note that in completing this booking form you undertake to adhere to the cancellation and payment terms listed below. Signature: Position: I cannot attend but please add me to your mailing list for future events. Please find cheque enclosed (please make payable to Euromoney Institutional Investor PLC) Date: REGISTRATION FEE: The registration fee includes participation in the forum, documentation material, breakfast, coffee breaks and lunch. All delegates are responsible for their own accommodation and travel. PAYMENT: All registration fees (where applicable) must be received in full prior to the event date. The information you provide on this form will be used by Euromoney Institutional Investor PLC and its group companies ( we or us ) to process your order and deliver the relevant products/services. We may also monitor your use of the website(s) relating to your order, including information you post and actions you take, to improve our services and track compliance with our terms of use. Except to the extent you indicate your objection below, we may also use your data (including data obtained from monitoring) (a) to keep you informed of our products and services; (b) occasionally to allow companies outside our group to contact you with details of their products/services; or (c) for our journalists to contact you for research purposes. As an international group, we may transfer your data on a global basis for the purposes indicated above, including to countries which may not provide the same level of protection to personal data as within the European Union. By submitting this order, you will be indicating your consent to the use of your data as identified above. Further detail on our use of your personal data is set out in our privacy policy, which is available at or can be provided to you separately upon request. If you object to contact by telephone, fax, or , or post, please tick the relevant box. If you do not want us to share your information with our journalists, or other companies please tick the relevant box.